Angela Matthews met her ovarian cancer diagnosis head-on because she wants to “hold her grandchildren one day.” Today, she is cancer-free.
Dr. Leslie M. Randall is an obstetrician-gynecologist in Orange, Calif. She completed her fellowship training with University of California, Irvine’s Division of Gynecologic Oncology and is skilled in the comprehensive medical and surgical care of women with all gynecologic cancers. Dr. Randall upholds many service commitments, including assistant professor at the University of California, Irvine, School of Medicine and director of education for gynecologic oncology.
Scientists continue to work toward a universal flu vaccine and alternate vaccine delivery systems in hopes of increasing vaccine rates.
Connie Sunderhaus, RN-B, a staffer at the Professional Patient Advocate Institute, discusses the increasing demand for patient advocacy.
An incorrect diagnosis of a rare form of cancer led to a new career as a patient advocate for Trisha Torrey.
Dr. Frederick M. Maynard is a recently retired physiatrist (a specialist in physical medicine and rehabilitation) who has dedicated a significant portion of his academic and clinical practice over the last 25 years to the unique problems of polio survivors. He is also a board member of Post Polio Health International (PPHI), whose mission is to enhance the lives and independence of polio survivors through education, advocacy, research and networking.
As a young girl, Karen Chase overcame the ravages of polio and later drew upon the experience to draft a riveting memoir.
Patient safety is an endemic concern — one that must be addressed by many stakeholders, including government agencies, manufacturers, healthcare providers and others, all working collectively to safely care for patients.
Dr. Terry Harville, a leading expert in the treatment of primary immunodeficiency diseases, was involved in the early stages of treatment options.
A diagnosis of primary immunodeficiency (PI) often leads to varying degrees of disability. For Brandon Dillon, it offered an opportunity to find untapped reserves of resilience.
With the growing demand for biologics, biosimilars promise additional treatment options, but their introduction is not without challenges.
Advances in treatment of this long-misunderstood disease allow patients like Daniel Kraus to lead normal, active lives.
